Peptide Skincare & BeautySkin science and ingredient guides

Ingredient or product comparison

Peptides for Skin Rejuvenation: Types Comparison

Before selecting a peptide sequence for research or formulation, understanding the mechanism, clinical evidence, and practical limitations is essential. The table below compares the most studied peptides for skin rejuvenation. GHK-Cu (copper peptide) TGF-β act

This source-based comparison does not add ratings or recommend a winner.

  • Before selecting a peptide sequence for research or formulation, understanding the mechanism, clinical evidence, and practical limitations is essential. The table below compares the most studied peptides for skin rejuvenation.
  • GHK-Cu (copper peptide)
  • TGF-β activation, TIMP stimulation, MMP inhibition
  • 18–23% increase in dermal collagen density after 12 weeks (multiple RCTs)
  • 1–3% topical
  • Strongest evidence base for collagen synthesis. Requires pH 5.5–6.5 for stability. Copper chelation is critical. Free GHK shows 60% reduced potency.
  • Palmitoyl pentapeptide-4 (Matrixyl)
  • Mimics type I procollagen C-terminal, direct fibroblast receptor binding
  • 17% wrinkle depth reduction after 8 weeks at 3% concentration
  • 2–5% topical
  • Lipophilic anchor improves sebum penetration. Clinical effect size smaller than GHK-Cu but faster onset (visible at 4 weeks).
  • Acetyl hexapeptide-8 (Argireline)
  • SNARE complex inhibition, acetylcholine release reduction
  • 27% wrinkle reduction after 30 days at 10% concentration
  • 5–10% topical
  • Mechanism is neuromuscular, not collagen synthesis. Effect duration 4–6 hours post-application. No long-term dermal remodeling.
  • Palmitoyl tripeptide-1
  • Collagen I/III gene expression upregulation, lipid bilayer penetration
  • 14% collagen increase after 12 weeks at 8% concentration (biopsy-confirmed)
  • Lower receptor affinity than GHK-Cu but better transdermal delivery. Ideal for combination formulations with retinoids.
  • Tripeptide-1 (GHK without copper)
  • Fibroblast signaling, weaker TGF-β activation
  • Approximately 40% of GHK-Cu effect at equivalent molar concentration
  • 3–5% topical
  • Cost-effective alternative when copper sensitivity is a concern. Requires higher concentration to match GHK-Cu efficacy.